Search
for
Sort by
Research 121–150 of 317
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- TOXIC EPIDERMAL NECROLYSIS
- Acneiform Dermatoses
- Update on the dermatologic use of systemic glucocorticosteroids
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Lupus panniculitis clinically simulating alopecia areata
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Psychodermatology
- Interventions for morphea
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- Characterization and causal investigations of an alopecia syndrome in Australian fur seals (<i>Arctocephalus pusillus doriferus</i>)
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Actinic superficial folliculitis
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Granulomatous pigmented purpuric dermatosis containing Propionibacterium acnes
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Crowdsourcing Dermatology Images with Google Search Ads: Creating a Real-World Skin Condition Dataset
- A Permanent Hair Loss in a Patient with Hypersensitivity to Intralesional Triamcinolone Injection